Fisher to distribute Response infectious disease tests in US
Response’s Flu A + B and RSV tests run on the RAMP 200 Reader diagnostic platform, which features multi-port capability to run up to 12 tests per hour
Ultragenyx Pharmaceutical has received accelerated approval from the US Food and Drug Administration (FDA) for its gene therapy, Genglycos (pariglasgene brecaparvovec-opnr), to treat glycogen storage disease type Ia (GSDIa).
BDSI claims that BNX, which uses BioErodible MucoAdhesive Technology (BEMA) and is formulated with naloxone to deliver buprenorphine for opioid dependence management, can be considered as an alternative
The acquisition will add BAC BV’s proprietary affinity ligands to Life Tech’s bioproduction portfolio of POROS chromatography resins, designed for purification of therapeutic products. Life Technologies bioproduction head